NCM
IDXX icon

Next Capital Management’s Idexx Laboratories IDXX Stock Holding History

Next Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-105
Closed -$29K – 138
2019
Q3 		$29K Sell
105
-86
-45% -$23.9K 0.02% 169
2019
Q2 		$53K Buy
191
+86
+82% +$21.2K 0.04% 157
2019
Q1 		$23K Hold
105
– – 0.02% 186
2018
Q4 		$20K Buy
+105
New +$21.5K 0.02% 167

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Next Capital Management's IDXX Position: Q4 2019 in Review

Next Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2019, closing a stake of 105 shares — an estimated $29K sold.

Next Capital Management first reported a position in IDXX in Q4 2018 and held it in 4 quarters. The position peaked at $53K in Q2 2019. 761 funds tracked by Wall St. Rank hold IDXX as of Q4 2019.

  • Next Capital Management reported no remaining Idexx Laboratories position as of Q4 2019 after selling out during the quarter.
  • Next Capital Management sold 105 Idexx Laboratories shares in Q4 2019, an estimated $29K.
  • Next Capital Management first reported a position in Idexx Laboratories in Q4 2018 and held it in 4 quarters.
  • Next Capital Management's Idexx Laboratories position peaked at $53K in Q2 2019.
  • 761 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2019.

Based on Next Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.